Back to User profile » Dr Aaron Ritter
Paper published by Dr Aaron Ritter:
Study Protocol
MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability, and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due to Alzheimer’s Disease
Decourt B, Wilson J, Ritter A, Dardis C, DiFilippo FP, Zhuang X, Cordes D, Lee G, Fulkerson ND, St Rose T, Hartley K, Sabbagh MN
Open Access Journal of Clinical Trials 2020, 12:1-13
Published Date: 7 January 2020